New guidelines on the management of anaphylaxis from the European Academy of Allergy and Clinical Immunology (EAACI) underscore the need to use intramuscular epinephrine as first-line treatment. The ...
At the American College of Allergy, Asthma & Immunology Annual Scientific Meeting, Jay A. Lieberman, MD, FACAAI, discussed upcoming changes to anaphylaxis guidelines and treatment strategies, ...
NHSBSA prescription data drives clinical research to enhance anaphylaxis management and patient safety14 January 2026Two new research papers show how NHS Business Services Authority (NHSBSA) ...
BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...
Please provide your email address to receive an email when new articles are posted on . Although current guidelines recommend calls to emergency medical services and ED visits in response to ...
AllergyAware e-learning course significantly improved school personnel's anaphylaxis knowledge and confidence in using epinephrine auto-injectors. Food allergies increase anaphylaxis risk, impacting ...
A study of more than 700,000 CT scans with iodinated contrast found an overall anaphylaxis incidence of 0.02%. Of these cases, 10% required three or more doses of epinephrine or initiation of IV ...
Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...
A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...
A new study by clinical researchers at Baylor College of Medicine and Texas Children’s Hospital offers insight on the primary triggers and management of childhood anaphylaxis. This severe, ...
Characterizing and learning from medical malpractice cases against medical oncologists using a national claims database. This is an ASCO Meeting Abstract from the 2022 ASCO Quality Care Symposium.
º Weight 10–25kg: 0.15mg epinephrine autoinjector, IM (anterior-lateral thigh) º Weight>25kg: 0.3mg epinephrine autoinjector, IM (anterior-lateral thigh) º Epinephrine (1:1000 solution) IM, 0.01mg/kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback